A Multicenter, Open Label, Non-Comparative Safety Study Of Maraviroc.
Phase of Trial: Phase III
Latest Information Update: 08 Sep 2011
At a glance
- Drugs Maraviroc (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions
- Sponsors ViiV Healthcare
- 10 Jun 2017 Biomarkers information updated
- 10 Nov 2010 Additional lead trial centre (ViiV Healthcare) identified as reported by ClinicalTrials.gov.
- 05 Oct 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.